Boston Scientific Carotid Stent Recall
Boston Scientific has issued a class 1 recall for their NexStent Monorail, NexStent Carotid Stent and Monorail Delivery System due to a defect which could allow the tip of the stent delivery system to detach while it is being implanted. This could pose a risk of serious and potentially fatal injury.
>>FDA LINK: Boston Scientific Stent Recall
The Boston Scientific stent recall was originally issued on June 6, 2008, but the notice was just posted on the FDA website today. The carotid stents were manufactured by Boston Scientific between June 12, 2007 and May 2, 2008, and distributed between June 19, 2007 and May 5, 2008 throughout the United States.
The stents are used to treat carotid artery disease, where the artery on either side of the neck that supplies blood to the brain is blocked. If the tip of the carotid stent delivery system detaches during the procedure, it could cause:
- Stroke
- Vessel Wall Injury
- Increased Procedure Time
- Emergency Surgery to Remove the Detached Stent Tip
According to information posted on the FDA website, the carotid stent recall does not affect stents that have already been implanted. Those who already have the stent implanted, and have not experienced problems can contact Boston Scientific at (763) 494-1700 with any questions or concerns.
BOSTON SCIENTIFIC CAROTID STENT LAWSUITS
The stent lawyers at Saiontz & Kirk, P.A. have been investigating lawsuits against Boston Scientific on behalf of clients who received the Taxus drug eluting heart stent. Potential claims are also being evaluated and reviewed for individuals who received the Boston Scientific NexStent Monorail, NexStent Carotid Stent and Monorail Delivery System, and suffered injuries as a result of the detachment of the tip of the carotid stent delivery system during the procedure.
If you, a friend or family member have suffered a stroke, vessel wall injury or additional surgical procedure to recover a detached stent tip, request a free consultation and claim evaluation.
No Comments • Add Your Comments